Editorial

DOI: 10.4244/EIJ-E-25-00038

Evolving cutoff values for optimising left main stenting with intravascular imaging

José M. de la Torre Hernandez1, MD, PhD

The value of intravascular imaging (IVI) to improve clinical outcomes after left main (LM) revascularisation has been the subject of multiple studies, with some attempting to identify specific minimum stent area (MSA) targets123.

It is worth noting that it is not just a matter of using IVI but of using it in an actionable way and oriented towards achieving certain targets, since the observable long-term prognostic benefit will depend on this4.

The group of investigators behind the study discussed in this editorial pioneered in defining these optimisation criteria, identifying an easy numerical series 5-6-7-8 mm2 for the MSA cutoff values in the ostial left circumflex (LCx), ostial left anterior descending (LAD), LM polygon of confluence, and LM above the polygon of confluence, respectively1.

These threshold values for MSA, derived from an Asian population, were notably lower than those found in a trial conducted in a Western population: 6, 7, and 10 mm2 for the LCx, LAD, and LM, respectively2.

Recently, the same authors revised the previous MSA criteria based on the 5-year clinical outcomes in patients undergoing upfront...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 18
Sep 15, 2025
Volume 21 Number 18
View full issue


Key metrics

Suggested by Cory
Trending articles
96.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
66.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.6

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.6

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
35.45

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved